Correlation between a pollen challenge chamber and a natural allergen exposure study design for eliciting ocular and nasal symptoms: Early evidence supporting a paradigm shift in drug investigation?

被引：16

作者：

Bernstein, Jonathan A. ^{[1
]}

机构：

[1] Univ Cincinnati, Div Immunol, Cincinnati, OH 45267 USA

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2012年 / 130卷 / 01期

关键词：

Pollen challenge chamber; environmental exposure unit; allergic rhinitis; ragweed; natural season; endotypes; ONSET; EFFICACY; PLACEBO; LORATADINE; CETIRIZINE; RHINITIS; RELIEF; SPRAY; UNIT;

D O I：

10.1016/j.jaci.2012.05.032

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：128 / 129

页数：2

共 15 条

[1]

Bernstein JA, 2012, ALLERGY ASTHMA PROC, V33, P1

[2] Effects of omalizumab on changes in pulmonary function induced by controlled cat room challenge [J].

Corren, Jonathan ;

Wood, Robert A. ;

Patel, Deepen ;

Zhu, Jin ;

Yegin, Ashley ;

Dhillon, Gitika ;

Fish, James E. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) :398-405

[3] Onset of action of intranasal budesonide (Rhinocort Aqua) in seasonal allergic rhinitis studied in a controlled exposure model [J].

Day, JH ;

Briscoe, MP ;

Rafeiro, E ;

Ellis, AK ;

Pettersson, E ;

Åkerlund, A .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (03) :489-494

[4] Experimental models for the evaluation of treatment of allergic rhinitis [J].

Day, JH ;

Ellis, AK ;

Rafeiro, E ;

Ratz, JD ;

Briscoe, MP .

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2006, 96 (02) :263-277

[5] Onset of action and efficacy of terfenadine, astemizole, cetirizine, and loratadine for the relief of symptoms of allergic rhinitis [J].

Day, JH ;

Briscoe, MP ;

Clark, RH ;

Ellis, AK ;

Gervais, P .

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1997, 79 (02) :163-172

[6] A randomized, double-blind, placebo-controlled, controlled antigen delivery study of the onset of action of aerosolized triamcinolone acetonide nasal spray in subjects with ragweed-induced allergic rhinitis [J].

Day, JH ;

Buckeridge, DL ;

Clark, RH ;

Briscoe, MP ;

Phillips, R .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 97 (05) :1050-1057

[7] Cetirizine, Ioratadine, or placebo in subjects with seasonal allergic rhinitis: Effects after controlled ragweed pollen challenge in an environmental exposure unit [J].

Day, JH ;

Briscoe, M ;

Widlitz, MD .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 101 (05) :638-645

[8] Onset of action, efficacy, and safety of a single dose of fexofenadine hydrochloride for ragweed allergy using an environmental exposure unit [J].

Day, JH ;

Briscoe, MP ;

Welsh, A ;

Smith, JN ;

Clark, A ;

Ellis, AK ;

Mason, J .

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1997, 79 (06) :533-540

[9] Comparative onset of action and symptom relief with cetirizine, loratadine, or placebo in an environmental exposure unit in subjects with seasonal allergic rhinitis: confirmation of a test system [J].

Day, JH ;

Briscoe, M ;

Rafeiro, E ;

Chapman, D ;

Kramer, B .

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2001, 87 (06) :474-481

[10] Efficacy of immunotherapy to ragweed antigen tested by controlled antigen exposure [J].

Donovan, JP ;

Buckeridge, DL ;

Briscoe, MP ;

Clark, RH ;

Day, JH .

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1996, 77 (01) :74-80

← 1 2 →